Tags

Type your tag names separated by a space and hit enter

An Advisory Committee Statement (ACS). Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on meningococcal vaccination for travellers.
Can Commun Dis Rep. 1999 Sep 15; 25:1-12.CC

Abstract

The Committee to Advise on Tropical Medicine and Travel (CATMAT) provides Health Canada with ongoing and timely medical, scientific, and public-health advice relating to tropical infectious disease and health risks associated with international travel. Health Canada acknowledges that the advice and recommendations set out in this statement are based upon the best current available scientific knowledge and medical practices, and is disseminating this document for information purposes to both travellers and the medical community caring for travellers. Persons administering or using drugs, vaccines, or other products should also be aware of the contents of the product monograph(s) or other similarly approved standards or instructions for use. Recommendations for use and other information set out herein may differ from that set out in the product monograph(s) or other similarly approved standards or instructions for use by the licensed manufacturer(s). Manufacturers have sought approval and provided evidence as to the safety and efficacy of their products only when used in accordance with the product monographs or other similarly approved standards or instructions for use.

Links

Publisher Full Text

MeSH

AdolescentAdultAfricaAge FactorsBacterial VaccinesCanadaChildChild, PreschoolEndemic DiseasesHealth EducationHumansImmunization ScheduleImmunization, SecondaryInfantMeningococcal InfectionsNeisseria meningitidisRisk FactorsTravelTropical ClimateTropical MedicineVaccination

Pub Type(s)

Journal Article

Language

eng fre

PubMed ID

10765571

Citation

"An Advisory Committee Statement (ACS). Committee to Advise On Tropical Medicine and Travel (CATMAT). Statement On Meningococcal Vaccination for Travellers." Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada, vol. 25, 1999, pp. 1-12.
An Advisory Committee Statement (ACS). Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on meningococcal vaccination for travellers. Can Commun Dis Rep. 1999;25:1-12.
(1999). An Advisory Committee Statement (ACS). Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on meningococcal vaccination for travellers. Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada, 25, 1-12.
An Advisory Committee Statement (ACS). Committee to Advise On Tropical Medicine and Travel (CATMAT). Statement On Meningococcal Vaccination for Travellers. Can Commun Dis Rep. 1999 Sep 15;25:1-12. PubMed PMID: 10765571.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - An Advisory Committee Statement (ACS). Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on meningococcal vaccination for travellers. PY - 2000/4/15/pubmed PY - 2000/4/15/medline PY - 2000/4/15/entrez SP - 1 EP - 12 JF - Canada communicable disease report = Releve des maladies transmissibles au Canada JO - Can Commun Dis Rep VL - 25 N2 - The Committee to Advise on Tropical Medicine and Travel (CATMAT) provides Health Canada with ongoing and timely medical, scientific, and public-health advice relating to tropical infectious disease and health risks associated with international travel. Health Canada acknowledges that the advice and recommendations set out in this statement are based upon the best current available scientific knowledge and medical practices, and is disseminating this document for information purposes to both travellers and the medical community caring for travellers. Persons administering or using drugs, vaccines, or other products should also be aware of the contents of the product monograph(s) or other similarly approved standards or instructions for use. Recommendations for use and other information set out herein may differ from that set out in the product monograph(s) or other similarly approved standards or instructions for use by the licensed manufacturer(s). Manufacturers have sought approval and provided evidence as to the safety and efficacy of their products only when used in accordance with the product monographs or other similarly approved standards or instructions for use. SN - 1188-4169 UR - https://www.unboundmedicine.com/medline/citation/10765571/An_Advisory_Committee_Statement__ACS___Committee_to_Advise_on_Tropical_Medicine_and_Travel__CATMAT___Statement_on_meningococcal_vaccination_for_travellers_ L2 - http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/99vol25/25sup/acs5.html DB - PRIME DP - Unbound Medicine ER -